C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2006
11/30/2006	US20060270045 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
11/30/2006	US20060270044 Compositions and methods for altering cellular functions
11/30/2006	US20060270043 Bacteria with reduced genome
11/30/2006	US20060270042 High-titer retroviral packaging cells
11/30/2006	US20060270041 Cell lines for production of replication-defective adenovirus
11/30/2006	US20060270040 Compositions and methods for treating tissue
11/30/2006	US20060270039 Method for inserting a nucleic acid of interest into a prokaryotic or eukaryotic cell by homologous recombination
11/30/2006	US20060270018 Bacteria for high efficiency cloning
11/30/2006	US20060270016 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
11/30/2006	US20060270013 Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways
11/30/2006	US20060270010 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/30/2006	US20060270008 Modified yeast consuming L-arabinose
11/30/2006	US20060270007 Method for producing glucoamylases and their uses
11/30/2006	US20060270006 Xylanases having increased stability in harsh industrial environments, such as increased pH and/or temperature
11/30/2006	US20060270005 Genomic library of cyanophage s-2l and functional analysis
11/30/2006	US20060270003 Nucleotide sequences coding imterleukin-17 polypeptide for use in diagnosis, prevention and treatment of bone, autoimmune, skin and inflammatory disorders
11/30/2006	US20060270002 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270001 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060270000 Factor VII or VIIa Polypeptide Variants
11/30/2006	US20060269999 Promoters
11/30/2006	US20060269998 Methods and compositions to modulate adhesion and stress tolerance in bacteria
11/30/2006	US20060269996 Human voltage gated sodium channel beta1A subunit and methods of use
11/30/2006	US20060269993 Mamalian chemokines and 7 transmembrane receptors; bound to MIP-3 alpha; labeled; fused to luciferase, bacterial beta -galactosidase, trpE, Protein A, beta -lactamase, alpha amylase, alcohol dehydrogenase, a FLAG tag, or yeast alpha mating factor; complexed with an antibody
11/30/2006	US20060269992 Producing a first thioredoxin polypeptide comprising thioredoxin, a modified thioredoxin, or a truncated thioredoxin; andincubating the first thioredoxin polypeptide with a protein-binding dye to form a first stained molecular weight marker
11/30/2006	US20060269988 Complete biosynthetic gene set for synthesis of polyketide antibiotics, including the albicidin family, resistance genes, and uses thereof
11/30/2006	US20060269977 Recombinant antibody recognizing dioxin and gene encoding the antibody
11/30/2006	US20060269975 Corynebacterium glutamicum genes encoding proteins involved in DNA replication, protein synthesis, and pathogenesis
11/30/2006	US20060269961 Dendrimer-based DNA extraction methods and biochips
11/30/2006	US20060269959 Sequences of an Ih ion channel and use thereof
11/30/2006	US20060269958 UV excitable energy transfer reagents
11/30/2006	US20060269956 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
11/30/2006	US20060269955 Isolation of proteins involved in posttranscriptional gene silencing and methods of use
11/30/2006	US20060269954 Self-assembling recombinant papillomavirus capsid proteins
11/30/2006	US20060269951 Inhibitors of autoinducer transporters
11/30/2006	US20060269940 Normalized nucleic acid libraries and methods of production thereof
11/30/2006	US20060269937 Assay for methylation in the GST-Pi gene
11/30/2006	US20060269933 Base sequence for control probe and method of designing the same
11/30/2006	US20060269920 Method for obtaining structural information about an encoded molecule
11/30/2006	US20060269913 Methods of producing dna and protein libraries
11/30/2006	US20060269912 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/30/2006	US20060269911 Antisense antiviral compound and method for treating ssRNA viral infection
11/30/2006	US20060269570 Recombinant double-stranded RNA phage, and use of the same
11/30/2006	US20060269566 Polypeptide comprising extracellular domain which induces T-cell proliferation response; gene therapy; vaccines; antiproliferative/antitumor agents; cytotoxic T-lymphocyte (CTLA)
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269563 NMB1343 from Neisseria meningitidis; provides a mutant toxin having a substitution at one or more of amino Glu-109, Glu-111 or Glu-120; has reduced or eliminated ADP-ribosyltransferase and/or NAD-glycohydrolase activity
11/30/2006	US20060269562 Polypeptides f' of the hepatitis c virus, t epitopeo, and the diagnostic and therapeutic applications thereof
11/30/2006	US20060269555 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders
11/30/2006	US20060269553 a protein conjugate comprising a physiologically active polypeptide, a non-peptide polymer and an immunoglobulin Fc fragment, with improved in vivo duration and stability; nonimmunogenic
11/30/2006	US20060269552 Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
11/30/2006	US20060269548 Lymphatic endothelial cells materials and methods
11/30/2006	US20060269547 Humanized anti-CD3 specific antibodies
11/30/2006	US20060269539 Genetic engineering; Alzheimer's agents; anticancer agents
11/30/2006	US20060269536 Inhibitor proteins of a protease and use thereof
11/30/2006	US20060269531 Apparatus for generating electrical pulses and methods of using the same
11/30/2006	US20060269530 RNA interference compositions and methods
11/30/2006	US20060269529 Modified t lymphocytes and uses therefor
11/30/2006	US20060269528 Production detection and use of transformant cells
11/30/2006	US20060269522 Sequence of natural or synthetic retroelements enabling nucleotide sequence insertion into a eukaryotic cell
11/30/2006	US20060269521 Avoidance of undesirable replication intermediates in plasmid propagation
11/30/2006	US20060269519 Modulation of cytokine signaling regulators and applications for immunotherapy
11/30/2006	US20060269518 Small interference rna gene therapy
11/30/2006	US20060269478 Use of protein occlusion for the selective delivery of small molecules to targets
11/30/2006	DE102005023829A1 Allele des opcA-Gens aus coryneformen Bakterien Alleles of the gene from coryneform bacteria opcA
11/30/2006	CA2614915A1 Methods for improving crop plant architecture and yield
11/30/2006	CA2609849A1 Chondrogenic compositions and methods of use
11/30/2006	CA2609817A1 Gene transfer method
11/30/2006	CA2609682A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
11/30/2006	CA2609593A1 Anti-cd16 binding molecules
11/30/2006	CA2609435A1 A process comprising codon optimization for the production of recombinant activated human protein c for the treatment of sepsis
11/30/2006	CA2609373A1 Method of producing liposomes containing gas enclosed therein
11/30/2006	CA2609365A1 Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (tina) and process for the preparation of tina
11/30/2006	CA2609276A1 Rapid production of adenovirus-free recombinant adenovirus vectors
11/30/2006	CA2609236A1 Elevation of oil in monocot plants
11/30/2006	CA2609218A1 Isothermal strand displacement amplification using primers containing a non-regular base
11/30/2006	CA2609164A1 Gene of transporter selective to mugineic acid-iron complex
11/30/2006	CA2609079A1 Nucleic acid molecules encoding echi-like polypeptides and methods of use
11/30/2006	CA2608850A1 Methods for diagnosing epigenetic, transgenerational effects of environmental toxicants on mammalian germ-lines and treating associated diseases
11/30/2006	CA2608841A1 Genetically modified microorganism and process for production of macrolide compound using the microorganism
11/30/2006	CA2608680A1 Controlled electroporation and mass transfer across cell membranes in tissue
11/30/2006	CA2607852A1 Transgenic alzheimer's mouse model vectors and uses thereof
11/30/2006	CA2606928A1 Transduction of primary cells
11/30/2006	CA2606801A1 Methods of producing and growing plants having improved phosphorus utilization
11/29/2006	EP1726663A1 Method of detecting gene mutation and kit for detecting gene mutation
11/29/2006	EP1726662A1 Instrument for detecting bacteria, method of detecting bacteria and kit for detecting bacteria
11/29/2006	EP1726661A1 Method for manufacturing a biosensor element
11/29/2006	EP1726658A2 Process for the preparation of dihydroxy esters and derivatives thereof
11/29/2006	EP1726657A1 Method of converting base in dna sequence
11/29/2006	EP1726656A2 Metalloproteinase-disintegrin family members: SVPH DNAs and polypeptides
11/29/2006	EP1726655A1 Beta fructofuranosidase mutant
11/29/2006	EP1726654A2 Polypeptide of n-acetylglucosamine-6-0-sulfotransferase and DNA encoding the same
11/29/2006	EP1726653A2 Genes coding for flavone synthases
11/29/2006	EP1726652A2 Delta 6-desaturases from primulaceae, expressing plants and PUFA-containing oils
11/29/2006	EP1726651A1 Method of treating muscular disorders
11/29/2006	EP1726650A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
11/29/2006	EP1726649A2 Peptide fragment having cytotoxicity-inhibitory activity and screening method for peptide fragment having said cytotoxicity-inhibitory activity
11/29/2006	EP1726648A1 Dna array and method of detecting single nucleotide polymorphism
11/29/2006	EP1726647A1 Gene promoting vascular endothelial cell growth
11/29/2006	EP1726646A1 Method of detecting carcinogenesis caused by hepatitis b virus
11/29/2006	EP1726645A1 Process for producing picolinic acid compounds
11/29/2006	EP1726644A1 Cellulase variants

1 ... 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 ... 4023